Skip to content

Clinical trials

Phase 2 Glomerulonephritis, IGA trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Country / region: Spain Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20191
20201
20214
20223
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Alexion Pharmaceuticals, Inc.2
ADARx Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
BioCryst Pharmaceuticals1
Calliditas Therapeutics AB1
Eledon Pharmaceuticals1
HI-Bio, A Biogen Company1
Josep m Cruzado1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA14
Glomerulonephritis3
Kidney Diseases3
Proteinuria3
Glomerulosclerosis, Focal Segmental2
Lupus Nephritis2
Nephritis, Hereditary2
Urologic Diseases2
Autoimmune Diseases1
Diabetic Nephropathies1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.